导读:对于70岁以上的低危早期乳腺癌患者来说,保乳术后是否要进行放疗或内分泌治疗?近期《Breast Cancer Research and Treatment》上发表了一篇题目为《Radiation and/or..
作者:肿瘤瞭望 有15887人浏览 发布于:2020-06-26
编者按:随着全球生物制剂市场份额的增加及各种生物制剂专利逐渐到期,生物类似药蜂拥而至。但国内的生物类似药较少,尚处于早期阶段。基于此现状,我们不禁要画个问号,生..
作者:肿瘤瞭望 有14549人浏览 发布于:2020-06-26
导读:HER2+早期乳腺癌是一种异质性疾病,包含所有乳腺癌本质亚型。目前唯一可用于抗HER2治疗选择的生物标志物是HER2状态本身,但雌激素受体(estrogen receptor,ER)状态..
作者:肿瘤瞭望 有19410人浏览 发布于:2020-06-25
In this interview, Dr. Peng Ling from the First Affiliated Hospital,School of Medicine, Zhejiang University, Dr. Mei Heng from the Union Hospital, Tongji M..
作者:肿瘤瞭望 有17045人浏览 发布于:2020-06-23
In this interview, Professor Xu Yingying from the First Affiliated Hospital of China Medical University will talk with Professor Javier Cortes from IOB, Insti..
作者:肿瘤瞭望 有16446人浏览 发布于:2020-06-23
Editor’s note: The annual meeting of American Society of Clinical Oncology (ASCO) was held in the form of online conference for the first time, the theme of ..
作者:肿瘤瞭望 有24266人浏览 发布于:2020-06-23
At the 2020 ASCO conference, Professor Thomas Powles from Barts Cancer Institute and the London School of Medicine and Dentistry, UK, has reported the JAVELI..
作者:肿瘤瞭望 有14004人浏览 发布于:2020-06-23
Editor’s note: May 29th, 2020 to 2nd June 2020, the annual meeting of the American Society of Clinical Oncology (ASCO) was held as a virtual meeting online ..
作者:肿瘤瞭望 有26952人浏览 发布于:2020-06-23
The Annual Meeting of American Society of Clinical Oncology (ASCO) this year was held on-line during 29/5 to 2/6. In the meeting, the Long-term result of trial..
作者:肿瘤瞭望 有13672人浏览 发布于:2020-06-23
编者按:2020年ASCO年会已在线上成功举办,在这场国际肿瘤学的奥斯卡盛典上,乳腺癌领域唯一一项入选LBA(Late-Breaking Abstract)的 ECOG-ACRIN 2108研究引起了专家学者..
作者:肿瘤瞭望 有13452人浏览 发布于:2020-06-23
来罗西利、恩替司他方案全线覆盖HR+/HER..
ESMO Asia大咖说丨佟仲生教授:DB-09研..
中国ADC“双擎驱动”丨大咖纷纭: A166、sa..
解除经济封印!RET/普拉替尼、KRAS G12C/..